Nomogram of conditional survival probability of long-term Survival for Metastatic Colorectal Cancer: A Real-World Data Retrospective Cohort Study from SEER database
- 4 July 2021
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in International Journal of Surgery
- Vol. 92, 106013
- https://doi.org/10.1016/j.ijsu.2021.106013
Abstract
Background: Many patients with metastatic colorectal cancer (mCRC) have better prognosis than the prediction at diagnosis. Compared with invariable traditional Kaplan Meier assessment, conditional survival (CS) assessment has become a more accurate and informative assessment method to predict survival time. Materials and methods Patients with mCRC between 2010 and 2015 were extracted from Surveillance, Epidemiology and End Results linked database. CS analysis was applied to depict exact survival for patients who have survived for specific year and standardized difference (d) was used to evaluate the differences between subgroups in CS analysis. Based on variables selected by Lasso analysis, nomograms for each year after diagnosis were fitted to estimate 3-year survival of stage IV CRC, respectively. Results: Of 9732 patients, overall actuarial survival (OS) decreased from 24% at 4-year to 16% at 6-year, while corresponding 3-year CS (CS3) increased from 33% at 1-year to 48% at 3-year. Overall, CS3 was higher than corresponding actuarial survival. All clinicopathological characteristics were associated with actuarial survival (p < 0.05). However, in CS3 analysis, survival difference caused by gender, race and tumor size gradually disappeared over time (|d|>0.1→ |d| 0→d<0 or d0). Based on lasso analysis, nomograms for 1st, 2nd and 3rd year after diagnosis were conducted respectively. The AUC of nomogram for 1st year was 0.705, for 2nd year was 0.675, and for 3rd year was 0.648. Conclusion: Patients with mCRC demonstrated a substantial increase in CS over time. Risk factors collected at diagnosis may change gradually. Nomograms constructed by survival time can predict more accurate survival for patients with mCRC. Conditional survival assessments provide important quantitative information about the probability of survival and are therefore of great value to patients and health care professionals.Keywords
Funding Information
- National Natural Science Foundation of China (81572351, 81871958, 16401970502, 17411951100, 19140902100)
- Science and Technology Commission of Shanghai Municipality (81572351, 81871958, 16401970502, 17411951100, 19140902100)
This publication has 18 references indexed in Scilit:
- Disparities in Colon Cancer Survival by Insurance Type: A Population-Based AnalysisDiseases of the Colon & Rectum, 2018
- The STROCSS statement: Strengthening the Reporting of Cohort Studies in SurgeryInternational Journal of Surgery, 2017
- Conditional Survival Among Cancer Patients in the United StatesThe Oncologist, 2010
- Conditional Survival after Surgical Resection of Colorectal Liver Metastasis: An International Multi-Institutional Analysis of 949 PatientsJournal of the American College of Surgeons, 2010
- Practical Application of a Calculator for Conditional Survival in Colon CancerJournal of Clinical Oncology, 2009
- Cancer Survival and Incidence from the Surveillance, Epidemiology, and End Results (SEER) ProgramThe Oncologist, 2003
- The conditional survival statistics for survivors with primary supratentorial astrocytic tumors.Journal of Neuro-Oncology, 2000
- Conditional Survival Among Patients With Carcinoma of the LungSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1999
- The conditional probability of survival of patients with primary malignant brain tumorsCancer, 1999
- Conditional survival of 56,268 patients with breast cancerCancer, 1995